DAPSONE GEL, 5%

DAPSONE GEL, 5% was reported 9933 times

DAPSONE GEL, 5% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAEMIA HEINZ BODY 7 0.4667
1 TYPE 1 LEPRA REACTION 17 0.3333
2 TYPE 2 LEPRA REACTION 49 0.2620
3 METHAEMOGLOBINAEMIA 494 0.2132
4 LEPROMATOUS LEPROSY 15 0.1765
5 BLOOD METHAEMOGLOBIN PRESENT 19 0.1712
6 HIV ASSOCIATED NEPHROPATHY 8 0.1569
7 TUBERCULOID LEPROSY 9 0.1385
8 MUCOCUTANEOUS LEISHMANIASIS 8 0.0656
9 AEROMONAS INFECTION 12 0.0635
10 MUCOUS MEMBRANE PEMPHIGOID 7 0.0619
11 DERMATITIS HERPETIFORMIS 14 0.0574
12 ALOPECIA SCARRING 10 0.0546
13 SERUM AMYLOID A PROTEIN INCREASED 8 0.0516
14 LEPROSY 9 0.0433
15 LEUKAEMOID REACTION 11 0.0423
16 LINEAR IGA DISEASE 63 0.0378
17 AUTOINFLAMMATORY DISEASE 8 0.0377
18 CHRONIC SPONTANEOUS URTICARIA 35 0.0302
19 ZYGOMYCOSIS 14 0.0299
20 CYANOSIS CENTRAL 7 0.0269
21 IDIOPATHIC PNEUMONIA SYNDROME 8 0.0268
22 PLEOCYTOSIS 15 0.0258
23 VANISHING BILE DUCT SYNDROME 28 0.0251
24 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 17 0.0232
25 MYCOBACTERIUM MARINUM INFECTION 7 0.0215
26 HAEMOLYTIC ANAEMIA 170 0.0190
27 URTICARIAL VASCULITIS 10 0.0189
28 IMMUNE RECONSTITUTION SYNDROME 23 0.0178
29 SKIN CANDIDA 9 0.0172
30 DISSEMINATED CRYPTOCOCCOSIS 13 0.0172
31 KAPOSI'S SARCOMA 8 0.0159
32 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 399 0.0155
33 JARISCH-HERXHEIMER REACTION 11 0.0154
34 NOCARDIOSIS 39 0.0152
35 PYODERMA GANGRENOSUM 54 0.0150
36 TOXOPLASMOSIS 15 0.0139
37 PNEUMONIA PSEUDOMONAL 21 0.0137
38 STEROID DEPENDENCE 12 0.0137
39 MARROW HYPERPLASIA 9 0.0132
40 COMPUTERISED TOMOGRAM THORAX ABNORMAL 9 0.0131
41 CEREBRAL ASPERGILLOSIS 8 0.0130
42 CORNEAL PERFORATION 8 0.0127
43 CRYOGLOBULINAEMIA 9 0.0126
44 MYCOBACTERIUM AVIUM COMPLEX INFECTION 33 0.0123
45 CENTRAL OBESITY 9 0.0122
46 CUSHINGOID 39 0.0121
47 LUNG TRANSPLANT REJECTION 8 0.0121
48 GRANULOMATOUS LIVER DISEASE 8 0.0114
49 FLUID IMBALANCE 8 0.0114
50 SUPERINFECTION BACTERIAL 9 0.0113
51 MYCOBACTERIUM ABSCESSUS INFECTION 8 0.0112
52 HAEMOLYSIS 85 0.0110
53 PRODUCT DELIVERY MECHANISM ISSUE 59 0.0110
54 LUPUS NEPHRITIS 20 0.0107
55 CHRONIC MYELOMONOCYTIC LEUKAEMIA 7 0.0106
56 BRAIN ABSCESS 26 0.0103
57 CEREBRAL TOXOPLASMOSIS 9 0.0096
58 EOSINOPHILIC MYOCARDITIS 7 0.0096
59 CYTOMEGALOVIRUS TEST POSITIVE 17 0.0095
60 LYMPHADENITIS 23 0.0095
61 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 22 0.0095
62 BONE DEMINERALISATION 10 0.0094
63 PULMONARY CAVITATION 8 0.0092
64 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 7 0.0091
65 THERAPEUTIC PRODUCT CROSS-REACTIVITY 8 0.0090
66 INFECTION REACTIVATION 10 0.0087
67 PEMPHIGOID 65 0.0086
68 URINARY TRACT INFECTION ENTEROCOCCAL 8 0.0086
69 NECROTISING FASCIITIS 30 0.0085
70 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
71 PNEUMONIA CRYPTOCOCCAL 8 0.0085
72 LYMPHOCYTIC INFILTRATION 8 0.0079
73 DIFFUSE ALVEOLAR DAMAGE 9 0.0078
74 ANAEMIA OF CHRONIC DISEASE 7 0.0077
75 CUTANEOUS LUPUS ERYTHEMATOSUS 15 0.0077
76 CYTOMEGALOVIRUS VIRAEMIA 34 0.0076
77 ACCIDENTAL POISONING 10 0.0073
78 RED BLOOD CELL ABNORMALITY 7 0.0073
79 HEPATORENAL SYNDROME 12 0.0071
80 HYPOCHROMIC ANAEMIA 7 0.0069
81 GRAFT VERSUS HOST DISEASE 49 0.0068
82 BONE MARROW TOXICITY 8 0.0068
83 WOUND COMPLICATION 23 0.0067
84 ANAEMIA MACROCYTIC 14 0.0066
85 VIRAEMIA 9 0.0065
86 TYPE 1 DIABETES MELLITUS 39 0.0065
87 MENINGITIS ASEPTIC 29 0.0065
88 EYELID IRRITATION 16 0.0064
89 KLEBSIELLA INFECTION 32 0.0063
90 PLATELET TRANSFUSION 8 0.0062
91 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11 0.0062
92 JUGULAR VEIN THROMBOSIS 11 0.0062
93 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
94 HYPERSENSITIVITY PNEUMONITIS 7 0.0061
95 NORMOCYTIC ANAEMIA 9 0.0061
96 PNEUMOMEDIASTINUM 11 0.0061
97 BLOOD PRESSURE SYSTOLIC ABNORMAL 15 0.0061
98 REBOUND EFFECT 68 0.0060
99 STEROID DIABETES 9 0.0060
100 CALCIPHYLAXIS 11 0.0060
101 PSEUDOMONAS INFECTION 51 0.0059
102 HIDRADENITIS 53 0.0058
103 STAPHYLOCOCCAL BACTERAEMIA 25 0.0057
104 HEPATITIS FULMINANT 17 0.0057
105 FANCONI SYNDROME ACQUIRED 10 0.0057
106 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0057
107 HYDRONEPHROSIS 42 0.0056
108 CD4 LYMPHOCYTES DECREASED 12 0.0056
109 STRONGYLOIDIASIS 9 0.0056
110 AUTOIMMUNE HAEMOLYTIC ANAEMIA 19 0.0055
111 PSEUDOMONAL SEPSIS 9 0.0051
112 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
113 INDURATION 9 0.0050
114 JC VIRUS INFECTION 8 0.0050
115 PNEUMOCYSTIS JIROVECII PNEUMONIA 50 0.0050
116 MYOPATHY 43 0.0050
117 GRANULOMA 17 0.0049
118 POST HERPETIC NEURALGIA 7 0.0049
119 NOROVIRUS INFECTION 7 0.0048
120 WOUND SECRETION 19 0.0048
121 SKIN ODOUR ABNORMAL 19 0.0048
122 SKIN INDURATION 10 0.0048
123 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
124 SUBCUTANEOUS ABSCESS 23 0.0048
125 APRAXIA 7 0.0047
126 ESCHERICHIA BACTERAEMIA 11 0.0047
127 BLOOD AMYLASE INCREASED 8 0.0047
128 APLASIA PURE RED CELL 16 0.0046
129 MYCOBACTERIAL INFECTION 8 0.0046
130 NEURITIS 7 0.0045
131 AREFLEXIA 12 0.0045
132 GLOMERULONEPHRITIS 11 0.0045
133 STEM CELL TRANSPLANT 11 0.0044
134 THERAPEUTIC PRODUCT INEFFECTIVE 17 0.0044
135 KIDNEY TRANSPLANT REJECTION 21 0.0044
136 TREATMENT FAILURE 359 0.0043
137 LUNG INFILTRATION 38 0.0043
138 LUNG ABSCESS 9 0.0043
139 LUNG CONSOLIDATION 12 0.0043
140 CYTOMEGALOVIRUS INFECTION 71 0.0043
141 PUSTULE 10 0.0042
142 BONE MARROW TRANSPLANT 8 0.0042
143 ECONOMIC PROBLEM 63 0.0042
144 BK VIRUS INFECTION 14 0.0041
145 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
146 BRONCHOPULMONARY ASPERGILLOSIS 31 0.0040
147 ANHEDONIA 105 0.0040
148 PRODUCT PHYSICAL CONSISTENCY ISSUE 22 0.0040
149 THERAPY PARTIAL RESPONDER 62 0.0040
150 CYTOMEGALOVIRUS COLITIS 9 0.0039
151 HYPOXIA 137 0.0039
152 GLUCOSE TOLERANCE IMPAIRED 23 0.0039
153 RENAL TRANSPLANT 14 0.0039
154 BLOOD HIV RNA INCREASED 7 0.0039
155 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 210 0.0038
156 PARADOXICAL DRUG REACTION 14 0.0038
157 ADENOVIRUS INFECTION 11 0.0038
158 HYPOVOLAEMIA 22 0.0038
159 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8 0.0038
160 ENTEROCOCCAL INFECTION 18 0.0037
161 LYMPHOCYTOSIS 8 0.0037
162 IMMUNE THROMBOCYTOPENIA 17 0.0037
163 NEPHROGENIC ANAEMIA 17 0.0037
164 HENOCH-SCHONLEIN PURPURA 8 0.0037
165 GRAFT VERSUS HOST DISEASE IN SKIN 8 0.0036
166 DERMATITIS EXFOLIATIVE 18 0.0036
167 HYPERPARATHYROIDISM SECONDARY 9 0.0036
168 RENAL TUBULAR NECROSIS 35 0.0036
169 END STAGE RENAL DISEASE 65 0.0036
170 CUTANEOUS VASCULITIS 13 0.0036
171 GENE MUTATION 7 0.0035
172 COMPLICATIONS OF TRANSPLANTED KIDNEY 8 0.0035
173 DISSEMINATED TUBERCULOSIS 9 0.0035
174 ASPERGILLUS INFECTION 23 0.0035
175 LIPIDS INCREASED 7 0.0035
176 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
177 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
178 NEPHROGENIC SYSTEMIC FIBROSIS 10 0.0033
179 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
180 OSTEOPENIA 50 0.0033
181 AZOTAEMIA 13 0.0033
182 SYNOVIAL CYST 15 0.0032
183 SKIN PAPILLOMA 13 0.0032
184 DRUG-INDUCED LIVER INJURY 101 0.0032
185 RENAL TUBULAR ACIDOSIS 7 0.0032
186 VENOOCCLUSIVE DISEASE 8 0.0032
187 SYSTEMIC CANDIDA 8 0.0032
188 ESCHERICHIA INFECTION 26 0.0032
189 PLATELET COUNT ABNORMAL 19 0.0031
190 CHEILITIS 17 0.0031
191 CYANOSIS 49 0.0031
192 CHRONIC GASTRITIS 7 0.0031
193 HEPATITIS TOXIC 8 0.0031
194 PNEUMONIA FUNGAL 12 0.0030
195 FLAT AFFECT 7 0.0030
196 BLOOD CULTURE POSITIVE 9 0.0030
197 NEPHRITIS 10 0.0030
198 PAPULE 21 0.0030
199 LEUKOENCEPHALOPATHY 11 0.0030
200 CYTOMEGALOVIRUS INFECTION REACTIVATION 13 0.0029
201 NEUTROPENIC SEPSIS 21 0.0029
202 BLOOD PHOSPHORUS INCREASED 8 0.0029
203 PANCYTOPENIA 163 0.0029
204 DERMATITIS BULLOUS 21 0.0029
205 BLOOD CREATININE ABNORMAL 10 0.0029
206 ENCEPHALITIS 20 0.0029
207 NECROSIS 16 0.0029
208 LUPUS-LIKE SYNDROME 26 0.0029
209 ACUTE RESPIRATORY FAILURE 55 0.0029
210 BONE MARROW FAILURE 58 0.0029
211 THERAPY NON-RESPONDER 128 0.0028
212 RHINOVIRUS INFECTION 11 0.0028
213 ORAL CANDIDIASIS 37 0.0028
214 PURULENT DISCHARGE 12 0.0028
215 HYPERBILIRUBINAEMIA 29 0.0028
216 RASH MACULO-PAPULAR 62 0.0028
217 BACTERIAL SEPSIS 9 0.0028
218 BLOOD PRESSURE DIASTOLIC ABNORMAL 7 0.0027
219 HEPATOSPLENOMEGALY 7 0.0027
220 SKIN PLAQUE 23 0.0027
221 HEPATITIS B 16 0.0027
222 HEPATIC NECROSIS 10 0.0027
223 HIV INFECTION 8 0.0027
224 BLOOD ALBUMIN DECREASED 21 0.0026
225 SKIN LESION 72 0.0026
226 ONYCHOMADESIS 11 0.0026
227 HAEMODIALYSIS 22 0.0026
228 OESOPHAGEAL ULCER 10 0.0026
229 MULTIPLE-DRUG RESISTANCE 8 0.0026
230 ULCER 41 0.0026
231 SKIN HYPERPIGMENTATION 22 0.0026
232 HEPATOMEGALY 25 0.0025
233 LEUKOCYTOSIS 46 0.0025
234 FOREIGN BODY IN THROAT 8 0.0025
235 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0025
236 SKIN NECROSIS 13 0.0025
237 CANDIDIASIS 10 0.0025
238 UROSEPSIS 23 0.0025
239 CHRONIC GRAFT VERSUS HOST DISEASE 9 0.0025
240 SQUAMOUS CELL CARCINOMA OF SKIN 15 0.0025
241 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0025
242 PLASMA CELL MYELOMA RECURRENT 8 0.0025
243 LYMPHOCYTE COUNT INCREASED 8 0.0024
244 ANGIOEDEMA 107 0.0024
245 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
246 LYME DISEASE 8 0.0024
247 PEMPHIGUS 30 0.0024
248 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18 0.0024
249 SEROTONIN SYNDROME 46 0.0024
250 PROTEIN TOTAL DECREASED 9 0.0024
251 GROWTH RETARDATION 7 0.0024
252 THROMBOTIC MICROANGIOPATHY 23 0.0024
253 HYPERCAPNIA 7 0.0023
254 APHTHOUS ULCER 18 0.0023
255 HERPES SIMPLEX 15 0.0023
256 BLOOD PRESSURE SYSTOLIC INCREASED 45 0.0023
257 OCULAR ICTERUS 10 0.0023
258 FIBROSIS 7 0.0023
259 BRONCHIOLITIS 8 0.0023
260 OESOPHAGEAL CANDIDIASIS 9 0.0023
261 QUALITY OF LIFE DECREASED 30 0.0022
262 HAEMOGLOBIN ABNORMAL 14 0.0022
263 PULMONARY HAEMORRHAGE 17 0.0022
264 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
265 GASTRIC ULCER HAEMORRHAGE 12 0.0022
266 JAUNDICE 58 0.0022
267 MULTIPLE MYELOMA 10 0.0021
268 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
269 COELIAC DISEASE 21 0.0021
270 ABSCESS 34 0.0021
271 OTITIS MEDIA 7 0.0021
272 FAILURE TO THRIVE 11 0.0021
273 OSTEOPOROSIS 87 0.0021
274 CLOSTRIDIUM DIFFICILE INFECTION 46 0.0021
275 SEPSIS 234 0.0021
276 STAPHYLOCOCCAL INFECTION 69 0.0021
277 CLOSTRIDIAL INFECTION 7 0.0021
278 BLOOD CREATININE INCREASED 135 0.0021
279 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 17 0.0021
280 VIRAL LOAD INCREASED 8 0.0021
281 VASCULITIS 24 0.0021
282 BASAL CELL CARCINOMA 32 0.0020
283 HYPERTRIGLYCERIDAEMIA 12 0.0020
284 PETECHIAE 21 0.0020
285 OXYGEN SATURATION DECREASED 113 0.0020
286 TRANSPLANT REJECTION 16 0.0020
287 NODULE 26 0.0020
288 DISEASE RECURRENCE 94 0.0020
289 LEUKOPENIA 98 0.0020
290 ANAEMIA 369 0.0019
291 STEVENS-JOHNSON SYNDROME 43 0.0019
292 BLOOD PHOSPHORUS DECREASED 7 0.0019
293 HEPATITIS 49 0.0019
294 SQUAMOUS CELL CARCINOMA 18 0.0019
295 FEBRILE NEUTROPENIA 126 0.0019
296 CHRONIC LYMPHOCYTIC LEUKAEMIA 9 0.0019
297 POLYARTHRITIS 10 0.0019
298 BLOOD BILIRUBIN INCREASED 51 0.0019
299 MENTAL STATUS CHANGES 52 0.0019
300 DERMATITIS 39 0.0019
301 OSTEONECROSIS 61 0.0019
302 BACTERAEMIA 22 0.0019
303 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
304 HYDROCEPHALUS 10 0.0018
305 AGRANULOCYTOSIS 34 0.0018
306 HYPOGAMMAGLOBULINAEMIA 12 0.0018
307 ERYTHEMA MULTIFORME 17 0.0018
308 DIFFUSE LARGE B-CELL LYMPHOMA 14 0.0018
309 ADRENAL INSUFFICIENCY 22 0.0018
310 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
311 DRUG ERUPTION 32 0.0018
312 SKIN MASS 12 0.0018
313 DRUG RESISTANCE 46 0.0018
314 TORSADE DE POINTES 14 0.0018
315 CHRONIC KIDNEY DISEASE 135 0.0018
316 CYST 22 0.0018
317 SUSPECTED OFF LABEL USE 8 0.0018
318 RENAL FAILURE ACUTE 75 0.0018
319 THROMBOCYTOPENIA 197 0.0018
320 DECREASED ACTIVITY 19 0.0018
321 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
322 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
323 CEREBRAL ISCHAEMIA 9 0.0017
324 RED BLOOD CELL COUNT DECREASED 50 0.0017
325 BLOOD DISORDER 14 0.0017
326 CYTOKINE RELEASE SYNDROME 35 0.0017
327 HERPES VIRUS INFECTION 10 0.0017
328 RENAL FAILURE 230 0.0017
329 WHITE BLOOD CELL COUNT ABNORMAL 11 0.0017
330 APLASTIC ANAEMIA 9 0.0017
331 HAEMATOCRIT DECREASED 34 0.0017
332 CARPAL TUNNEL SYNDROME 24 0.0017
333 ARTHRITIS BACTERIAL 7 0.0017
334 HYPERURICAEMIA 7 0.0017
335 ACIDOSIS 13 0.0017
336 SKIN TIGHTNESS 8 0.0017
337 APPLICATION SITE EXFOLIATION 7 0.0017
338 LYMPHADENOPATHY 59 0.0017
339 GANGRENE 10 0.0017
340 RESPIRATORY FAILURE 121 0.0017
341 FOETAL GROWTH RESTRICTION 10 0.0016
342 PHOTOSENSITIVITY REACTION 27 0.0016
343 LYMPHOPENIA 23 0.0016
344 BLOOD PRESSURE DIASTOLIC DECREASED 12 0.0016
345 PANCREATIC DISORDER 8 0.0016
346 STREPTOCOCCAL INFECTION 9 0.0016
347 DRUG TOXICITY 22 0.0016
348 RENAL IMPAIRMENT 135 0.0016
349 ECCHYMOSIS 11 0.0016
350 ACUTE KIDNEY INJURY 245 0.0016
351 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
352 LIPASE INCREASED 12 0.0016
353 MULTI-ORGAN FAILURE 27 0.0016
354 TACHYPNOEA 21 0.0015
355 PHOTOPHOBIA 29 0.0015
356 EOSINOPHILIA 27 0.0015
357 HEPATIC FAILURE 46 0.0015
358 SCAR 26 0.0015
359 BLOOD LACTIC ACID INCREASED 8 0.0015
360 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43 0.0015
361 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
362 LIVER FUNCTION TEST ABNORMAL 44 0.0015
363 RENAL CYST 12 0.0015
364 SKIN ULCER 39 0.0015
365 CELLULITIS 76 0.0015
366 PHARYNGOLARYNGEAL PAIN 8 0.0015
367 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
368 PLASMA CELL MYELOMA 58 0.0015
369 IMMUNOSUPPRESSION 13 0.0015
370 ENCEPHALOPATHY 36 0.0015
371 GINGIVAL BLEEDING 20 0.0015
372 RESPIRATORY RATE INCREASED 13 0.0015
373 BLISTER 82 0.0015
374 FAECALOMA 8 0.0015
375 HYPERKALAEMIA 51 0.0015
376 SPINAL COMPRESSION FRACTURE 12 0.0014
377 SPLENOMEGALY 17 0.0014
378 OLIGURIA 9 0.0014
379 RASH VESICULAR 7 0.0014
380 HAEMODYNAMIC INSTABILITY 11 0.0014
381 COVID-19 PNEUMONIA 17 0.0014
382 BLOOD UREA INCREASED 24 0.0014
383 OFF LABEL USE 1252 0.0014
384 UPPER RESPIRATORY TRACT INFECTION 66 0.0014
385 RESPIRATORY DISTRESS 39 0.0014
386 ACUTE MYELOID LEUKAEMIA 22 0.0014
387 IMMUNODEFICIENCY 21 0.0014
388 CHOLESTASIS 27 0.0014
389 SEPTIC SHOCK 61 0.0014
390 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41 0.0014
391 PRODUCT CONTAINER ISSUE 12 0.0014
392 FULL BLOOD COUNT DECREASED 28 0.0014
393 CYTOPENIA 17 0.0014
394 SMALL INTESTINAL OBSTRUCTION 17 0.0014
395 PRODUCT USE IN UNAPPROVED INDICATION 342 0.0014
396 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
397 AMMONIA INCREASED 7 0.0014
398 GROIN PAIN 12 0.0014
399 MYASTHENIA GRAVIS 11 0.0014
400 PNEUMONITIS 37 0.0014
401 POOR VENOUS ACCESS 14 0.0014
402 MENINGITIS 9 0.0013
403 ATELECTASIS 13 0.0013
404 PULMONARY MASS 20 0.0013
405 BACTERIAL INFECTION 25 0.0013
406 PYREXIA 463 0.0013
407 PNEUMOTHORAX 21 0.0013
408 HEPATOTOXICITY 29 0.0013
409 PLATELET COUNT DECREASED 138 0.0013
410 CATARACT 77 0.0013
411 METABOLIC ACIDOSIS 41 0.0013
412 ANURIA 11 0.0013
413 HAEMOGLOBIN DECREASED 131 0.0013
414 NEUTROPENIA 173 0.0013
415 EMOTIONAL DISTRESS 154 0.0013
416 BLOOD IRON DECREASED 15 0.0013
417 MENTAL DISORDER 55 0.0013
418 DRUG INTOLERANCE 122 0.0013
419 PROTEINURIA 24 0.0013
420 DEEP VEIN THROMBOSIS 82 0.0013
421 NEUROPATHY PERIPHERAL 120 0.0013
422 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
423 HYPERLIPIDAEMIA 15 0.0013
424 LABORATORY TEST ABNORMAL 37 0.0013
425 MALNUTRITION 14 0.0013
426 SKIN INFECTION 14 0.0012
427 FLUID OVERLOAD 18 0.0012
428 HEPATITIS ACUTE 8 0.0012
429 NEUROLOGICAL SYMPTOM 7 0.0012
430 LETHARGY 70 0.0012
431 INTENTIONAL PRODUCT USE ISSUE 106 0.0012
432 BLOOD PRESSURE FLUCTUATION 29 0.0012
433 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
434 DRUG INTERACTION 191 0.0012
435 FUNGAL INFECTION 40 0.0012
436 PNEUMONIA BACTERIAL 11 0.0012
437 PRODUCT PRESCRIBING ISSUE 26 0.0012
438 PNEUMONIA 384 0.0012
439 MUCOSAL INFLAMMATION 31 0.0012
440 PLEURAL EFFUSION 72 0.0012
441 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
442 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
443 ACUTE HEPATIC FAILURE 16 0.0012
444 BLOOD POTASSIUM INCREASED 19 0.0012
445 SKIN DISORDER 39 0.0012
446 EYE MOVEMENT DISORDER 8 0.0012
447 LYMPHOMA 18 0.0012
448 ANOREXIA 15 0.0012
449 WHITE BLOOD CELL COUNT DECREASED 126 0.0012
450 BLOOD MAGNESIUM DECREASED 10 0.0012
451 TENDERNESS 12 0.0012
452 CONDITION AGGRAVATED 350 0.0011
453 DERMATITIS ACNEIFORM 7 0.0011
454 COAGULOPATHY 19 0.0011
455 SCRATCH 12 0.0011
456 HYPERCALCAEMIA 14 0.0011
457 PURPURA 10 0.0011
458 NEUTROPHIL COUNT DECREASED 46 0.0011
459 VITAMIN D DEFICIENCY 11 0.0011
460 SYSTEMIC LUPUS ERYTHEMATOSUS 40 0.0011
461 IMPAIRED HEALING 37 0.0011
462 HYPERGLYCAEMIA 41 0.0011
463 TRANSAMINASES INCREASED 25 0.0011
464 DELIRIUM 39 0.0011
465 NIGHT SWEATS 36 0.0011
466 BONE DENSITY DECREASED 35 0.0011
467 RASH PAPULAR 25 0.0011
468 BRAIN OEDEMA 14 0.0011
469 PULMONARY HYPERTENSION 23 0.0011
470 GASTROENTERITIS 16 0.0011
471 MOUTH ULCERATION 23 0.0011
472 ORAL DISORDER 8 0.0011
473 RASH PRURITIC 59 0.0011
474 RASH ERYTHEMATOUS 52 0.0011
475 IRON DEFICIENCY ANAEMIA 10 0.0011
476 DIVERTICULITIS 30 0.0011
477 EYELID PTOSIS 11 0.0011
478 HYPOPHOSPHATAEMIA 8 0.0011
479 PERICARDIAL EFFUSION 25 0.0011
480 EOSINOPHIL COUNT INCREASED 9 0.0011
481 TREATMENT NONCOMPLIANCE 59 0.0011
482 HYPOMAGNESAEMIA 15 0.0011
483 EAR DISCOMFORT 11 0.0011
484 NEPHROPATHY TOXIC 12 0.0011
485 OBESITY 17 0.0011
486 DIALYSIS 15 0.0011
487 GENERALISED OEDEMA 13 0.0010
488 DISEASE PROGRESSION 124 0.0010
489 PYELONEPHRITIS 9 0.0010
490 POSTOPERATIVE WOUND INFECTION 7 0.0010
491 MUSCLE ATROPHY 13 0.0010
492 AUTOIMMUNE DISORDER 10 0.0010
493 NEPHROTIC SYNDROME 7 0.0010
494 OEDEMA PERIPHERAL 123 0.0010
495 DYSPNOEA EXERTIONAL 38 0.0010
496 LARGE INTESTINE PERFORATION 7 0.0010
497 HYPERTRANSAMINASAEMIA 7 0.0010
498 ASPIRATION 11 0.0010
499 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
500 ALANINE AMINOTRANSFERASE INCREASED 61 0.0010
501 PULMONARY TOXICITY 7 0.0010
502 HAND FRACTURE 7 0.0010
503 GLAUCOMA 19 0.0010
504 NO THERAPEUTIC RESPONSE 12 0.0010
505 PULMONARY EMBOLISM 93 0.0010
506 FISTULA 11 0.0010
507 RASH MACULAR 34 0.0010
508 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
509 PERSONALITY CHANGE 9 0.0010
510 EMBOLISM 8 0.0010
511 LYMPHOCYTE COUNT DECREASED 17 0.0010
512 CANDIDA INFECTION 16 0.0009
513 OSTEOMYELITIS 17 0.0009
514 DIZZINESS POSTURAL 9 0.0009
515 HERPES ZOSTER 53 0.0009
516 PRODUCTIVE COUGH 44 0.0009
517 AORTIC ANEURYSM 7 0.0009
518 OESOPHAGITIS 10 0.0009
519 SKIN EXFOLIATION 77 0.0009
520 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
521 SPINAL OSTEOARTHRITIS 8 0.0009
522 IMMUNE SYSTEM DISORDER 12 0.0009
523 RENAL FAILURE CHRONIC 7 0.0009
524 SINUS DISORDER 18 0.0009
525 VENTRICULAR TACHYCARDIA 15 0.0009
526 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
527 HYPERTENSION 192 0.0009
528 HAEMATURIA 31 0.0009
529 OEDEMA 49 0.0009
530 RESPIRATORY DISORDER 27 0.0009
531 FOOT DEFORMITY 10 0.0009
532 VENTRICULAR FIBRILLATION 10 0.0009
533 HYPOALBUMINAEMIA 7 0.0009
534 HYPOCALCAEMIA 17 0.0009
535 BRAIN INJURY 9 0.0009
536 CARDIOMEGALY 11 0.0009
537 GASTROINTESTINAL INFLAMMATION 7 0.0009
538 SKIN DISCOLOURATION 41 0.0009
539 MYOSITIS 8 0.0009
540 AFFECTIVE DISORDER 7 0.0009
541 FACE OEDEMA 15 0.0009
542 TOOTH ABSCESS 9 0.0009
543 URTICARIA 148 0.0009
544 HYPOTENSION 177 0.0009
545 CHILLS 103 0.0009
546 DERMATITIS CONTACT 10 0.0009
547 DERMATITIS ALLERGIC 11 0.0009
548 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42 0.0009
549 VIRAL INFECTION 29 0.0009
550 RETINAL DETACHMENT 8 0.0009
551 BONE LOSS 13 0.0009
552 TRANSFUSION 9 0.0009
553 MASS 12 0.0009
554 WOUND 24 0.0009
555 LUNG DISORDER 42 0.0009
556 NEPHROPATHY 8 0.0009
557 LIVER INJURY 21 0.0009
558 BLINDNESS UNILATERAL 12 0.0008
559 ASCITES 25 0.0008
560 SPINAL FRACTURE 17 0.0008
561 PRODUCT PHYSICAL ISSUE 17 0.0008
562 HAEMATOTOXICITY 8 0.0008
563 EYE INFLAMMATION 8 0.0008
564 TASTE DISORDER 17 0.0008
565 LUNG INFECTION 13 0.0008
566 GASTRITIS 22 0.0008
567 PULMONARY FIBROSIS 16 0.0008
568 MYELODYSPLASTIC SYNDROME 12 0.0008
569 BIPOLAR DISORDER 9 0.0008
570 LOCALISED INFECTION 20 0.0008
571 SHOCK 19 0.0008
572 NOCTURIA 10 0.0008
573 RASH 356 0.0008
574 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
575 ADVERSE DRUG REACTION 73 0.0008
576 DEHYDRATION 108 0.0008
577 MUSCLE STRAIN 7 0.0008
578 INFECTION 117 0.0008
579 PANCREATITIS ACUTE 18 0.0008
580 DIABETES MELLITUS 61 0.0008
581 C-REACTIVE PROTEIN INCREASED 29 0.0008
582 BLOOD SODIUM DECREASED 15 0.0008
583 EMPHYSEMA 8 0.0008
584 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
585 DRUG INEFFECTIVE 1036 0.0008
586 INSURANCE ISSUE 12 0.0008
587 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
588 NEUTROPHIL COUNT INCREASED 8 0.0008
589 DEVICE RELATED INFECTION 12 0.0008
590 HIP FRACTURE 25 0.0008
591 TACHYCARDIA 69 0.0008
592 RASH GENERALISED 20 0.0008
593 BRONCHITIS 57 0.0008
594 PLATELET COUNT INCREASED 10 0.0008
595 CARDIOGENIC SHOCK 11 0.0008
596 SKIN IRRITATION 35 0.0008
597 FOLLICULITIS 8 0.0008
598 APHASIA 23 0.0008
599 INCREASED TENDENCY TO BRUISE 7 0.0008
600 ANAPHYLACTIC REACTION 42 0.0008
601 PULMONARY OEDEMA 34 0.0008
602 GRAND MAL CONVULSION 7 0.0008
603 SARS-COV-2 TEST POSITIVE 10 0.0008
604 ASTHENIA 283 0.0008
605 HYPOTHYROIDISM 24 0.0008
606 RENAL DISORDER 35 0.0008
607 HEPATIC ENCEPHALOPATHY 7 0.0007
608 ORTHOSTATIC HYPOTENSION 13 0.0007
609 JOINT RANGE OF MOTION DECREASED 10 0.0007
610 HEPATIC CIRRHOSIS 14 0.0007
611 NEUROTOXICITY 13 0.0007
612 RENAL INJURY 22 0.0007
613 ABDOMINAL PAIN 172 0.0007
614 GASTROINTESTINAL DISORDER 66 0.0007
615 GASTRIC ULCER 14 0.0007
616 SKIN LACERATION 8 0.0007
617 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
618 BLOOD POTASSIUM DECREASED 22 0.0007
619 MULTIPLE FRACTURES 12 0.0007
620 TENDON RUPTURE 9 0.0007
621 THERAPEUTIC RESPONSE DECREASED 44 0.0007
622 ILEUS 9 0.0007
623 MOBILITY DECREASED 52 0.0007
624 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
625 BODY TEMPERATURE DECREASED 7 0.0007
626 HEPATIC ENZYME INCREASED 48 0.0007
627 IMPAIRED WORK ABILITY 15 0.0007
628 NEURALGIA 17 0.0007
629 LIVER DISORDER 31 0.0007
630 PARALYSIS 10 0.0007
631 FOOT FRACTURE 13 0.0007
632 THROMBOSIS 55 0.0007
633 PULMONARY CONGESTION 9 0.0007
634 WEIGHT INCREASED 152 0.0007
635 RECTAL HAEMORRHAGE 29 0.0007
636 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
637 HAEMORRHAGE INTRACRANIAL 10 0.0007
638 INJECTION SITE REACTION 46 0.0007
639 PAIN OF SKIN 18 0.0007
640 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
641 PANCREATITIS 35 0.0007
642 IMPAIRED GASTRIC EMPTYING 9 0.0007
643 COLITIS 25 0.0007
644 DYSPNOEA 373 0.0007
645 BONE DISORDER 12 0.0007
646 PRESYNCOPE 16 0.0007
647 ANXIETY 187 0.0007
648 CONFUSIONAL STATE 106 0.0007
649 INTENTIONAL OVERDOSE 42 0.0007
650 LIVER FUNCTION TEST INCREASED 14 0.0007
651 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0006
652 ANKLE FRACTURE 10 0.0006
653 HEPATIC FUNCTION ABNORMAL 24 0.0006
654 PULMONARY THROMBOSIS 7 0.0006
655 HYPONATRAEMIA 36 0.0006
656 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
657 BODY TEMPERATURE INCREASED 13 0.0006
658 SINUSITIS 65 0.0006
659 DENTAL CARIES 7 0.0006
660 HYPOKALAEMIA 29 0.0006
661 BLOOD PRESSURE INCREASED 96 0.0006
662 DIARRHOEA 402 0.0006
663 INFUSION SITE PAIN 8 0.0006
664 WEIGHT DECREASED 172 0.0006
665 MUSCULAR WEAKNESS 70 0.0006
666 ERYTHEMA 126 0.0006
667 MICTURITION URGENCY 7 0.0006
668 DEPRESSION 139 0.0006
669 CARDIAC FAILURE 49 0.0006
670 GASTROENTERITIS VIRAL 11 0.0006
671 NEOPLASM 7 0.0006
672 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
673 DISORIENTATION 24 0.0006
674 ELECTROLYTE IMBALANCE 7 0.0006
675 EAR INFECTION 16 0.0006
676 CONSTIPATION 131 0.0006
677 FATIGUE 467 0.0006
678 COUGH 168 0.0006
679 HYPOAESTHESIA ORAL 9 0.0006
680 ATRIAL FIBRILLATION 58 0.0006
681 CONVULSION 34 0.0006
682 BLOOD COUNT ABNORMAL 9 0.0006
683 NO ADVERSE EVENT 107 0.0006
684 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42 0.0006
685 LIMB INJURY 16 0.0006
686 BLINDNESS 24 0.0006
687 INFUSION RELATED REACTION 39 0.0006
688 SWELLING 55 0.0006
689 HYPOPHAGIA 15 0.0006
690 CONTUSION 56 0.0006
691 NAUSEA 458 0.0006
692 RESPIRATORY TRACT INFECTION 15 0.0006
693 VOMITING 270 0.0006
694 BRAIN FOG 9 0.0006
695 INFLUENZA 64 0.0006
696 PAIN 351 0.0006
697 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
698 BLOOD TEST ABNORMAL 8 0.0006
699 AMNESIA 37 0.0006
700 DECREASED APPETITE 132 0.0006
701 CHEST PAIN 105 0.0006
702 ABNORMAL WEIGHT GAIN 7 0.0006
703 SEASONAL ALLERGY 8 0.0006
704 PERIPHERAL SWELLING 87 0.0006
705 URINARY TRACT INFECTION 96 0.0006
706 CORONARY ARTERY DISEASE 17 0.0006
707 DRY EYE 28 0.0006
708 KIDNEY INFECTION 11 0.0006
709 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
710 INTERSTITIAL LUNG DISEASE 27 0.0006
711 LACTIC ACIDOSIS 18 0.0006
712 TOOTHACHE 10 0.0006
713 DYSPHAGIA 52 0.0005
714 OSTEOARTHRITIS 23 0.0005
715 UNRESPONSIVE TO STIMULI 14 0.0005
716 PSYCHOTIC DISORDER 16 0.0005
717 CARDIOMYOPATHY 8 0.0005
718 HIATUS HERNIA 7 0.0005
719 SKIN HAEMORRHAGE 8 0.0005
720 TOOTH DISORDER 12 0.0005
721 DIPLOPIA 14 0.0005
722 PRODUCT DOSE OMISSION ISSUE 158 0.0005
723 MYALGIA 91 0.0005
724 CARDIAC ARREST 44 0.0005
725 FLUID RETENTION 27 0.0005
726 MUSCLE SPASMS 97 0.0005
727 PRODUCT AVAILABILITY ISSUE 12 0.0005
728 PRODUCT USE ISSUE 99 0.0005
729 BLOOD PRESSURE DECREASED 35 0.0005
730 ABASIA 13 0.0005
731 EYE HAEMORRHAGE 7 0.0005
732 PARANOIA 9 0.0005
733 POST PROCEDURAL COMPLICATION 10 0.0005
734 VISION BLURRED 71 0.0005
735 MUSCULOSKELETAL CHEST PAIN 8 0.0005
736 DYSURIA 19 0.0005
737 LOCAL SWELLING 9 0.0005
738 HYPOGLYCAEMIA 25 0.0005
739 DYSSTASIA 15 0.0005
740 IRRITABLE BOWEL SYNDROME 11 0.0005
741 PRURITUS 197 0.0005
742 HEART RATE DECREASED 18 0.0005
743 SKIN FISSURES 10 0.0005
744 SKIN CANCER 11 0.0005
745 GENERAL PHYSICAL HEALTH DETERIORATION 59 0.0005
746 PRURITUS GENERALISED 11 0.0005
747 ISCHAEMIC STROKE 9 0.0005
748 RESPIRATORY TRACT CONGESTION 8 0.0005
749 GASTROINTESTINAL HAEMORRHAGE 42 0.0005
750 HAEMOPTYSIS 14 0.0005
751 COORDINATION ABNORMAL 7 0.0005
752 APHONIA 7 0.0005
753 DRUG EFFECT INCOMPLETE 18 0.0005
754 ILL-DEFINED DISORDER 30 0.0005
755 HEPATOCELLULAR INJURY 7 0.0005
756 TOXICITY TO VARIOUS AGENTS 83 0.0005
757 HAEMATOCHEZIA 27 0.0005
758 ASTHMA 55 0.0005
759 RIB FRACTURE 10 0.0005
760 DRUG LEVEL INCREASED 8 0.0005
761 EPISTAXIS 36 0.0005
762 LIP SWELLING 16 0.0005
763 GAIT INABILITY 16 0.0005
764 PALLOR 13 0.0005
765 SWELLING FACE 31 0.0005
766 TYPE 2 DIABETES MELLITUS 16 0.0005
767 ACNE 36 0.0005
768 ACUTE MYOCARDIAL INFARCTION 14 0.0005
769 ABDOMINAL PAIN LOWER 12 0.0005
770 COVID-19 83 0.0005
771 MYELOSUPPRESSION 17 0.0005
772 SLEEP APNOEA SYNDROME 9 0.0005
773 HYPERSENSITIVITY 87 0.0005
774 GASTRIC DISORDER 16 0.0005
775 HERNIA 9 0.0005
776 PRODUCT QUALITY ISSUE 63 0.0005
777 HAEMATOMA 12 0.0005
778 EAR PAIN 9 0.0005
779 SYNCOPE 46 0.0005
780 ECZEMA 24 0.0005
781 DIABETIC KETOACIDOSIS 11 0.0005
782 HIP ARTHROPLASTY 7 0.0005
783 INTENTIONAL DOSE OMISSION 13 0.0005
784 PALPITATIONS 53 0.0005
785 BACK PAIN 105 0.0005
786 UPPER LIMB FRACTURE 9 0.0005
787 BLOOD CHOLESTEROL INCREASED 21 0.0005
788 ABDOMINAL DISTENSION 47 0.0004
789 GAIT DISTURBANCE 86 0.0004
790 HOSPITALISATION 69 0.0004
791 SUICIDAL IDEATION 41 0.0004
792 THIRST 8 0.0004
793 GOUT 8 0.0004
794 STOMATITIS 27 0.0004
795 HEADACHE 279 0.0004
796 OCULAR HYPERAEMIA 21 0.0004
797 COMA 21 0.0004
798 HYPOAESTHESIA 66 0.0004
799 CYSTITIS 14 0.0004
800 CARDIAC FAILURE CONGESTIVE 35 0.0004
801 TOOTH LOSS 9 0.0004
802 TREMOR 72 0.0004
803 MUSCULOSKELETAL STIFFNESS 38 0.0004
804 CONJUNCTIVITIS 8 0.0004
805 HEPATIC STEATOSIS 8 0.0004
806 LOSS OF CONSCIOUSNESS 55 0.0004
807 SUICIDE ATTEMPT 26 0.0004
808 COGNITIVE DISORDER 20 0.0004
809 CHOLELITHIASIS 14 0.0004
810 SLEEP DISORDER 30 0.0004
811 DYSARTHRIA 16 0.0004
812 HEART RATE INCREASED 42 0.0004
813 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
814 MALAISE 185 0.0004
815 WHEEZING 25 0.0004
816 VISUAL ACUITY REDUCED 14 0.0004
817 URINARY RETENTION 14 0.0004
818 CEREBRAL HAEMORRHAGE 15 0.0004
819 BALANCE DISORDER 36 0.0004
820 NEPHROLITHIASIS 19 0.0004
821 HEMIPARESIS 7 0.0004
822 MELAENA 9 0.0004
823 NASAL CONGESTION 24 0.0004
824 POLLAKIURIA 17 0.0004
825 DIZZINESS 203 0.0004
826 INFLAMMATION 21 0.0004
827 CARDIO-RESPIRATORY ARREST 17 0.0004
828 OSTEONECROSIS OF JAW 10 0.0004
829 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
830 HAEMORRHAGE 42 0.0004
831 SNEEZING 9 0.0004
832 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
833 MUSCULOSKELETAL PAIN 21 0.0004
834 FEELING ABNORMAL 96 0.0004
835 OROPHARYNGEAL PAIN 37 0.0004
836 PREGNANCY 8 0.0004
837 ABDOMINAL DISCOMFORT 67 0.0004
838 ARTHRALGIA 162 0.0004
839 ILLNESS 40 0.0004
840 FLATULENCE 22 0.0004
841 FALL 129 0.0004
842 PRODUCT SUBSTITUTION ISSUE 22 0.0004
843 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
844 FEELING HOT 23 0.0004
845 INSOMNIA 99 0.0004
846 URINARY INCONTINENCE 11 0.0004
847 FIBROMYALGIA 9 0.0004
848 UNEVALUABLE EVENT 28 0.0004
849 FRACTURE 7 0.0004
850 NASOPHARYNGITIS 68 0.0004
851 PARAESTHESIA 58 0.0004
852 FEELING JITTERY 7 0.0004
853 INJECTION SITE URTICARIA 9 0.0004
854 MOOD ALTERED 10 0.0004
855 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
856 INFLUENZA LIKE ILLNESS 30 0.0004
857 APPLICATION SITE PAIN 8 0.0004
858 AGEUSIA 9 0.0004
859 DERMATITIS ATOPIC 19 0.0004
860 RHABDOMYOLYSIS 15 0.0004
861 DEPRESSED MOOD 19 0.0004
862 HAEMORRHOIDS 7 0.0004
863 BONE PAIN 21 0.0004
864 BRADYCARDIA 19 0.0004
865 EMOTIONAL DISORDER 11 0.0004
866 CHROMATURIA 8 0.0004
867 ALOPECIA 69 0.0004
868 VISUAL IMPAIRMENT 43 0.0003
869 FEEDING DISORDER 7 0.0003
870 DEAFNESS 9 0.0003
871 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0003
872 DYSPHONIA 20 0.0003
873 PERITONITIS 7 0.0003
874 EXPOSURE DURING PREGNANCY 21 0.0003
875 THROAT IRRITATION 15 0.0003
876 CHEST DISCOMFORT 34 0.0003
877 LACRIMATION INCREASED 10 0.0003
878 MENTAL IMPAIRMENT 8 0.0003
879 SOMNOLENCE 66 0.0003
880 CEREBRAL INFARCTION 8 0.0003
881 EYE PRURITUS 11 0.0003
882 ABNORMAL DREAMS 9 0.0003
883 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
884 NERVOUSNESS 17 0.0003
885 SPEECH DISORDER 17 0.0003
886 ABORTION SPONTANEOUS 13 0.0003
887 ARTHROPATHY 18 0.0003
888 JOINT SWELLING 39 0.0003
889 FEMUR FRACTURE 10 0.0003
890 EYE SWELLING 12 0.0003
891 DRY SKIN 43 0.0003
892 NERVOUS SYSTEM DISORDER 10 0.0003
893 INTENTIONAL PRODUCT MISUSE 28 0.0003
894 AGGRESSION 16 0.0003
895 PAIN IN EXTREMITY 94 0.0003
896 ARTHRITIS 25 0.0003
897 HAEMATEMESIS 8 0.0003
898 FLUSHING 32 0.0003
899 HYPERSOMNIA 9 0.0003
900 BURNING SENSATION 22 0.0003
901 MOOD SWINGS 10 0.0003
902 COLITIS ULCERATIVE 14 0.0003
903 MEMORY IMPAIRMENT 43 0.0003
904 ERECTILE DYSFUNCTION 8 0.0003
905 ABDOMINAL PAIN UPPER 64 0.0003
906 RHINORRHOEA 20 0.0003
907 DYSPEPSIA 30 0.0003
908 TINNITUS 14 0.0003
909 MIGRAINE 29 0.0003
910 INJECTION SITE SWELLING 23 0.0003
911 PREMATURE BABY 9 0.0003
912 FEAR 8 0.0003
913 DISTURBANCE IN ATTENTION 16 0.0003
914 THROAT TIGHTNESS 8 0.0003
915 ARRHYTHMIA 14 0.0003
916 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
917 SEIZURE 34 0.0003
918 THERAPY INTERRUPTED 21 0.0003
919 INJECTION SITE RASH 9 0.0003
920 LUNG NEOPLASM MALIGNANT 12 0.0003
921 PRODUCT DOSE OMISSION 19 0.0003
922 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
923 CEREBROVASCULAR ACCIDENT 49 0.0003
924 NIGHTMARE 10 0.0003
925 CARDIAC DISORDER 27 0.0003
926 BLOOD GLUCOSE INCREASED 54 0.0003
927 NECK PAIN 16 0.0003
928 AGITATION 21 0.0003
929 INJURY 20 0.0003
930 EYE PAIN 16 0.0003
931 PAIN IN JAW 8 0.0003
932 RHEUMATOID ARTHRITIS 32 0.0003
933 ABNORMAL BEHAVIOUR 11 0.0003
934 INJECTION SITE BRUISING 22 0.0003
935 CARDIOVASCULAR DISORDER 7 0.0003
936 DEATH 236 0.0003
937 EYE DISORDER 9 0.0003
938 THERAPY CESSATION 14 0.0003
939 HYPERHIDROSIS 35 0.0003
940 DYSKINESIA 11 0.0003
941 MEDICATION ERROR 15 0.0003
942 JOINT STIFFNESS 7 0.0003
943 DISCOMFORT 16 0.0003
944 EYE IRRITATION 15 0.0003
945 ADVERSE EVENT 24 0.0003
946 DRUG DOSE OMISSION 43 0.0003
947 NEOPLASM PROGRESSION 9 0.0003
948 MYOCARDIAL INFARCTION 45 0.0003
949 SWOLLEN TONGUE 8 0.0003
950 DYSGEUSIA 19 0.0003
951 HYPOACUSIS 11 0.0003
952 RESPIRATORY ARREST 7 0.0003
953 DEMENTIA 7 0.0003
954 INJECTION SITE ERYTHEMA 31 0.0002
955 DRY MOUTH 20 0.0002
956 VERTIGO 15 0.0002
957 ANGINA PECTORIS 7 0.0002
958 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
959 PSORIASIS 31 0.0002
960 NEOPLASM MALIGNANT 15 0.0002
961 SKIN BURNING SENSATION 16 0.0002
962 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
963 CRYING 8 0.0002
964 PANIC ATTACK 8 0.0002
965 HALLUCINATION 16 0.0002
966 INTESTINAL OBSTRUCTION 8 0.0002
967 ANGER 7 0.0002
968 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
969 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
970 SURGERY 11 0.0002
971 BLOOD GLUCOSE DECREASED 9 0.0002
972 INJECTION SITE PRURITUS 12 0.0002
973 EXTRA DOSE ADMINISTERED 7 0.0002
974 PSORIATIC ARTHROPATHY 7 0.0002
975 IRRITABILITY 10 0.0002
976 DRUG DEPENDENCE 23 0.0001
977 INCORRECT DOSE ADMINISTERED 31 0.0001
978 OVERDOSE 29 0.0001
979 DRUG EFFECT DECREASED 7 0.0001
980 COMPLETED SUICIDE 10 0.0001
981 HOT FLUSH 9 0.0001
982 DEVICE MALFUNCTION 8 0.0001
983 INJECTION SITE HAEMORRHAGE 9 0.0001
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
986 INJECTION SITE PAIN 33 0.0001
987 BREAST CANCER 9 0.0001
988 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
989 PROSTATE CANCER 7 0.0001
990 DEVICE ISSUE 7 0.0001